Peripheral Markers of Suicidal Behavior: Current Findings and Clinical Implications
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Biomarkers of suicidal behavior (SB), particularly peripheral biomarkers, may aid in the development of preventive and intervention strategies. The peripheral biomarkers of SB should be easily accessible, cost-effective, and minimally invasive. To identify peripheral biomarkers of SB, we summarized the current knowledge related to SB biomarkers with a focus on suicidal outcomes (suicidal ideation [SI], suicide risk [SR], suicide attempt [SA], and suicide death [SD]), measured site (center or periphery), and study design (cross-sectional or longitudinal). We also evaluated the central findings to validate the findings of peripheral biomarkers of SB. We found reduced peripheral interleukin (IL)-2 levels in individuals with a recent SA, higher cerebrospinal fluid (CSF) IL-6 levels in patients with a current SR and future SD, higher CSF tumor necrosis factor-α levels for current and future SRs, higher high-sensitivity C-reactive protein levels and lower peripheral total cholesterol levels for recent SAs, lower peripheral 5-HT levels for present SR, and a lower folate level for future SR and SA within 1 year. Previous studies have shown inconsistent associations of low peripheral leptin levels with SR and recent SA; therefore, further study is required. Given the multiple determinants of SB and weak associations with single biological markers, combinations of potential biological markers rather than single markers may improve the screening, diagnosis, and prediction of SB.
Abstract
Biomarkers of suicidal behavior (SB), particularly peripheral biomarkers, may aid in the development of preventive and intervention strategies. The peripheral biomarkers of SB should be easily accessible, cost-effective, and minimally invasive. To identify peripheral biomarkers of SB, we summarized the current knowledge related to SB biomarkers with a focus on suicidal outcomes (suicidal ideation [SI], suicide risk [SR], suicide attempt [SA], and suicide death [SD]), measured site (center or periphery), and study design (cross-sectional or longitudinal). We also evaluated the central findings to validate the findings of peripheral biomarkers of SB. We found reduced peripheral interleukin (IL)-2 levels in individuals with a recent SA, higher cerebrospinal fluid (CSF) IL-6 levels in patients with a current SR and future SD, higher CSF tumor necrosis factor-α levels for current and future SRs, higher high-sensitivity C-reactive protein levels and lower peripheral total cholesterol levels for recent SAs, lower peripheral 5-HT levels for present SR, and a lower folate level for future SR and SA within 1 year. Previous studies have shown inconsistent associations of low peripheral leptin levels with SR and recent SA; therefore, further study is required. Given the multiple determinants of SB and weak associations with single biological markers, combinations of potential biological markers rather than single markers may improve the screening, diagnosis, and prediction of SB.
참고문헌 (99)
- Blasco-Fontecilla H, "Predicting suicidal behavior: Are we really that far along? Comment on “Discovery and validation of blood biomarkers for suicidality.”", Curr Psychiatry Rep, 15, pp.424~ (2013)
- Yeonsoo Park, "Frontal Alpha Asymmetry Correlates with Suicidal Behavior in Major Depressive Disorder", Clinical Psychopharmacology and Neuroscience, 17(3), pp.377~387 (2019), 대한정신약물학회[DOI]
- Jae Seok Lim, "Prediction Models for Suicide Attempts among Adolescents Using Machine Learning Techniques", Clinical Psychopharmacology and Neuroscience, 20(4), pp.609~620 (2022), 대한정신약물학회[DOI]
- Zhou Y, "Suicide and suicide behaviors : A review of transcriptomics and multiomics studies in psychiatric disorders", J Neurosci Res, 98, pp.601~615 (2020)
- Johnston JN, "Suicide biomarkers to predict risk, classify diagnostic subtypes, and identify novel therapeutic targets : 5years of promising research", Int J Neuropsychopharmacol, 25, pp.197~214 (2022)
- Metin Atescelik, "The Relationship between Ghrelin and Copeptin Levels, and Anxiety and Depression Levels in Suicide Attempts", Clinical Psychopharmacology and Neuroscience, 15(3), pp.256~260 (2017), 대한정신약물학회[DOI]
- Al-Amarei H, "C-reactive protein and its relationship with lipid profile in suicidal and non suicidal adults with major depression", Indian J Public Health Res Dev, 10, pp.569~573 (2019)
- Black C, "Meta-analysis of cytokines and chemokines in suicidality : Distinguishing suicidal versus nonsuicidal patients", Biol Psychiatry, 78, pp.28~37 (2015)
- Ducasse D, "A metaanalysis of cytokines in suicidal behavior", Brain Behav Immun, 46, pp.203~211 (2015)
- González-Castro TB, "Interleukin-6 levels in serum, plasma, and cerebral spinal fluid in individuals with suicide behavior : Systematic review and meta-analysis with meta-regression", J Interferon Cytokine Res, 41, pp.258~267 (2021)
- Messaoud A, "Investigation of the relationship among cortisol, pro-inflammatory cytokines, and the degradation of tryptophan into kynurenine in patients with major depression and suicidal behavior", Curr Top Med Chem, 22, pp.2119~2125 (2022)
- Martinez JM, "Proinflammatory and"resiliency"proteins in the CSF of patients with major depression", Depress Anxiety, 29, pp.32~38 (2012)
- Sowa-Kućma M, "Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder : Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts", Prog Neuropsychopharmacol Biol Psychiatry, 81, pp.372~383 (2018)
- Schiweck C, "Childhood trauma, suicide risk and inflammatory phenotypes of depression : Insights from monocyte gene expression", Transl Psychiatry, 10, pp.296~ (2020)
- Isung J, "Low plasma vascular endothelial growth factor(VEGF)associated with completed suicide", World J Biol Psychiatry, 13, pp.468~473 (2012)
- Gabbay V, "A preliminary study of cytokines in suicidal and nonsuicidal adolescents with major depression", J Child Adolesc Psychopharmacol, 19, pp.423~430 (2009)
- Keaton SA, "An inflammatory profile linked to increased suicide risk", J Affect Disord, 247, pp.57~65 (2019)
- Jha MK, "Dysfunctional adaptive immune response in adolescents and young adults with suicide behavior", Psychoneuroendocrinology, 111, pp.104487~ (2020)
- Su YA, "Associations among serum markers of inflammation, life stress and suicide risk in patients with major depressive disorder", J Psychiatr Res, 129, pp.53~60 (2020)
- Bastos CR, "Polymorphism in CRHR1 gene affects the IL-1βlevels in suicidal attempters", J Psychiatr Res, 86, pp.34~38 (2017)
- Coryell W, "Latent infection, inflammatory markers and suicide attempt history in depressive disorders", J Affect Disord, 270, pp.97~101 (2020)
- Huang TL, "T-helper 1", T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression, 2007, pp.61, 415~420
- Melhem NM, "Blunted HPA axis activity prior to suicide attempt and increased inflammation in attempters", Psychoneuroendocrinology, 77, pp.284~294 (2017)
- Lindqvist D, "Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity", Biol Psychiatry, 66, pp.287~292 (2009)
- Lindqvist D, "CSF biomarkers in suicide attempters--a principal component analysis", Acta Psychiatr Scand, 124, pp.52~61 (2011)
- Pandey GN, "Abnormal protein and mRNA expression of inflammatory cytokines in the prefrontal cortex of depressed individuals who died by suicide", J Psychiatry Neurosci, 43, pp.376~385 (2018)
- Devorak J, "Cellular and molecular inflammatory profile of the choroid plexus in depression and suicide", Front Psychiatry, 6, pp.138~ (2015)
- Tonelli LH, "Elevated cytokine expression in the orbitofrontal cortex of victims of suicide", Acta Psychiatr Scand, 117, pp.198~206 (2008)
- Kim YK, "Differences in cytokines between non-suicidal patients and suicidal patients in major depression", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.356~361 (2008)
- Janelidze S, "Cytokine levels in the blood may distinguish suicide attempters from depressed patients", Brain Behav Immun, 25, pp.335~339 (2011)
- O’Donovan A, "Suicidal ideation is associated with elevated inflammation in patients with major depressive disorder", Depress Anxiety, 30, pp.307~314 (2013)
- Goldstein BI, "Inflammatory markers among adolescents and young adults with bipolar spectrum disorders", J Clin Psychiatry, 76, pp.1556~1563 (2015)
- Vargas HO, "Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts", J Affect Disord, 150, pp.923~930 (2013)
- Isung J, "Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters", Transl Psychiatry, 2, pp.e196~ (2012)
- Hoyo-Becerra C, "Concomitant interferon alpha stimulation and TLR3 activation induces neuronal expression of depression-related genes that are elevated in the brain of suicidal persons", PLoS One, 8, pp.e83149~ (2013)
- Juengst SB, "Exploratory associations with tumor necrosis factor-α, disinhibition and suicidal endorsement after traumatic brain injury", Brain Behav Immun, 41, pp.134~143 (2014)
- Thompson D, "The physiological structure of human C-reactive protein and its complex with phosphocholine", Structure, 7, pp.169~177 (1999)
- Chen X, "Increased C-reactive protein concentrations were associated with suicidal behavior in patients with depressive disorders : A meta-analysis", Psychiatry Res, 292, pp.113320~ (2020)
- Miola A, "Increased C-reactive protein concentration and suicidal behavior in people with psychiatric disorders : A systematic review and meta-analysis", Acta Psychiatr Scand, 144, pp.537~552 (2021)
- Gambi F, "A retrospective evaluation of the inflammatory marker C-reactive protein(CRP), cholesterol and high-density lipoproteins in patients with major depression : Preliminary findings", Eur J Inflamm, 3, pp.127~134 (2005)
- Gohar SM, "Association between leptin levels and severity of suicidal behaviour in schizophrenia spectrum disorders", Acta Psychiatr Scand, 139, pp.464~471 (2019)
- Courtet P, "Increased CRP levels may be a trait marker of suicidal attempt", Eur Neuropsychopharmacol, 25, pp.1824~1831 (2015)
- da Graça Cantarelli M, "Serum triglycerides, but not cholesterol or leptin, are decreased in suicide attempters with mood disorders", J Affect Disord, 172, pp.403~409 (2015)
- Kim DJ, "Examination of pain threshold and neuropeptides in patients with acute suicide risk", Prog Neuropsychopharmacol Biol Psychiatry, 95, pp.109705~ (2019)
- Aguglia A, "Predictors of relapse in high lethality suicide attempters : A six-month prospective study", J Affect Disord, 271, pp.328~335 (2020)
- Peng R, "Low serum free thyroxine level is correlated with lipid profile in depressive patients with suicide attempt", Psychiatry Res, 266, pp.111~115 (2018)
- Russell AE, "Evidence for an association between inflammatory markers and suicide : a cohort study based on 359, 849 to 462, 747 Taiwanese adults", J Affect Disord, 281, pp.967~971 (2021)
- Cantarelli Mda G, "Potential neurochemical links between cholesterol and suicidal behavior", Psychiatry Res, 220, pp.745~751 (2014)
- Wu S, "Serum lipid levels and suicidality : A meta-analysis of 65 epidemiological studies", J Psychiatry Neurosci, 41, pp.56~69 (2016)
- Li H, "Association between serum lipid concentrations and attempted suicide in patients with major depressive disorder : A meta-analysis", PLoS One, 15, pp.e0243847~ (2020)
- Sankaranarayanan A, "Serum lipids and suicidal risk among patients with schizophrenia spectrum disorders : Systematic review and meta-analysis", Acta Psychiatr Scand, 144, pp.125~152 (2021)
- Lalovic A, "Cholesterol content in brains of suicide completers", Int J Neuropsychopharmacol, 10, pp.159~166 (2007)
- Freemantle E, "Cholesterol and phospholipids in frontal cortex and synaptosomes of suicide completers : Relationship with endosomal lipid trafficking genes", J Psychiatr Res, 47, pp.272~279 (2013)
- Oquendo MA, "Toward a biosignature for suicide", Am J Psychiatry, 171, pp.1259~1277 (2014)
- Mann JJ, "The neurobiology and genetics of suicide and attempted suicide : A focus on the serotonergic system", Neuropsychopharmacology, 24, pp.467~477 (2001)
- O’Connor TM, "The stress response and the hypothalamic-pituitary-adrenal axis : From molecule to melancholia", QJM, 93, pp.323~333 (2000)
- O’Connor DB, "Cortisol levels and suicidal behavior : A meta-analysis", Psychoneuroendocrinology, 63, pp.370~379 (2016)
- Hernández-Díaz Y, "The role of peripheral cortisol levels in suicide behavior : A systematic review and meta-analysis of 30 studies", Psychiatry Res, 293, pp.113448~ (2020)
- Brunner J, "Vasopressin in CSF and plasma in depressed suicide attempters : Preliminary results", Eur Neuropsychopharmacol, 12, pp.489~494 (2002)
- Giurgiuca A, "Cortisol levels and suicide in bipolar I disorder", Acta Endocrinol(Buchar), 13, pp.188~194 (2017)
- Lindqvist D, "Suicidal intent and the HPA-axis characteristics of suicide attempters with major depressive disorder and adjustment disorders", Arch Suicide Res, 12, pp.197~207 (2008)
- Gartland N, "Effects of childhood adversity and cortisol levels on suicidal ideation and behaviour : Results from a general population study", Psychoneuroendocrinology, 138, pp.105664~ (2022)
- Chatzittofis A, "CSF 5-HIAA, cortisol and DHEAS levels in suicide attempters", Eur Neuropsychopharmacol, 23, pp.1280~1287 (2013)
- Secunda SK, "Biochemistry and suicidal behavior in depressed patients", Biol Psychiatry, 21, pp.756~767 (1986)
- Jokinen J, "Noradrenergic function and HPA axis dysregulation in suicidal behaviour", Psychoneuroendocrinology, 35, pp.1536~1542 (2010)
- Dwivedi Y, "The neurobiological basis of suicide", pp.2012, CRC Press
- Pillai A, "Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects : Correlation with plasma BDNF and psychopathology", Int J Neuropsychopharmacol, 13, pp.535~539 (2010)
- Garcia R, "Stress, metaplasticity, and antidepressants", Curr Mol Med, 2, pp.629~638 (2002)
- Henningsson S, "Genetic variation in brain-derived neurotrophic factor is associated with serotonin transporter but not serotonin-1A receptor availability in men", Biol Psychiatry, 66, pp.477~485 (2009)
- Eisen RB, "Association between BDNF levels and suicidal behaviour : A systematic review and meta-analysis", Syst Rev, 4, pp.187~ (2015)
- Fusar-Poli L, "Peripheral BDNF levels in psychiatric patients with and without a history of suicide attempt : A systematic review and meta-analysis", Prog Neuropsychopharmacol Biol Psychiatry, 111, pp.110342~ (2021)
- Kim YK, "Low plasma BDNF is associated with suicidal behavior in major depression", Prog Neuropsychopharmacol Biol Psychiatry, 31, pp.78~85 (2007)
- Kudinova AY, "Circulating levels of brain-derived neurotrophic factor and history of suicide attempts in women", Suicide Life Threat Behav, 49, pp.54~63 (2019)
- Sher L, "Brain-derived neurotrophic factor in war veterans with or without a history of suicide attempt", J Affect Disord, 308, pp.160~165 (2022)
- Dwivedi Y, "Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects", Arch Gen Psychiatry, 60, pp.804~815 (2003)
- Gadad BS, "Altered levels of interleukins and neurotrophic growth factors in mood disorders and suicidality : An analysis from periphery to central nervous system", Transl Psychiatry, 11, pp.341~ (2021)
- Marcinko D, "Platelet serotonin and serum cholesterol concentrations in suicidal and non-suicidal male patients with a first episode of psychosis", Psychiatry Res, 150, pp.105~108 (2007)
- Spreux-Varoquaux O, "Differential abnormalities in plasma 5-HIAA and platelet serotonin concentrations in violent suicide attempters : Relationships with impulsivity and depression", Life Sci, 69, pp.647~657 (2001)
- paroxetine binding correlate with recurrence of suicidal behavior, "Psychopharmacology(Berl)", 1997, 89~94
- Roaldset JO, "A prospective study of lipids and serotonin as risk markers of violence and self-harm in acute psychiatric patients", Psychiatry Res, 186, pp.293~299 (2011)
- Grah M, "Serotonin and cortisol as suicidogenic factors in patients with PTSD", Coll Antropol, 34, pp.1433~1439 (2010)
- Giurgiuca A, "Platelet serotonin as biomarker for assessing suicidal behaviour in patients with bipolar I disorder", Acta Endocrinol(Buchar), 12, pp.275~281 (2016)
- Messaoud A, "Reduced peripheral availability of tryptophan and increased activation of the kynurenine pathway and cortisol correlate with major depression and suicide", World J Biol Psychiatry, 20, pp.703~711 (2019)
- Dogan KH, "Evaluation of postmortem cerebrospinal fluid S100B protein and serotonin levels : comparison of suicidal versus nonsuicidal deaths in Konya, Turkey", J Forensic Sci, 61, pp.1285~1291 (2016)
- Korpi ER, "Serotonin and 5-hydroxyindoleacetic acid in brains of suicide victims. Comparison in chronic schizophrenic patients with suicide as cause of death", Arch Gen Psychiatry, 43, pp.594~600 (1986)
- Francisco V, "Obesity, fat mass and immune system : Role for leptin", Front Physiol, 9, pp.640~ (2018)
- González-Castro TB, "Evaluation of leptin levels in serum as a biomarker for suicide behavior : Systematic review and meta-analysis", Int J Neurosci, 131, pp.49~55 (2021)
- Atmaca M, "Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts", Acta Psychiatr Scand, 108, pp.208~214 (2003)
- Ayesa-Arriola R, "Low-density lipoprotein cholesterol and suicidal behaviour in a large sample of first-episode psychosis patients", World J Biol Psychiatry, 19(sup3), pp.S158~S161 (2018)
- Lalovic A, "Altered expression of lipid metabolism and immune response genes in the frontal cortex of suicide completers", J Affect Disord, 120, pp.24~31 (2010)
- Cantoni GL, "S-adenosylmethionine; A new intermediate formed enzymatically from L-methionine and adenosinetriphosphate", J Biol Chem, 204, pp.403~416 (1953)
- Bottiglieri T, "The clinical potential of ademetionine(S-adenosylmethionine)in neurological disorders", Drugs, 48, pp.137~152 (1994)
- Wolfersdorf M, "Red-cell and serum folate levels in depressed inpatients who commit violent suicide : A comparison with control groups", Pharmacopsychiatry, 28, pp.77~79 (1995)
- Kim JM, "Prediction of suicidality according to serum folate levels in depressive patients receiving stepwise pharmacotherapy", Front Psychiatry, 12, pp.747228~ (2021)
- Bai S, "Potential biomarkers for diagnosing major depressive disorder patients with suicidal ideation", J Inflamm Res, 14, pp.495~503 (2021)
- Domenico De Berardis, "Alexithymia, Suicide Ideation and Homocysteine Levels in Drug Naïve Patients with Major Depression: A Study in the “Real World” Clinical Practice", Clinical Psychopharmacology and Neuroscience, 17(2), pp.318~322 (2019), 대한정신약물학회[DOI]
- Coryell W, "Combined biological tests for suicide prediction", Psychiatry Res, 150, pp.187~191 (2007)
- Kim JM, "Multiple serum biomarkers for predicting suicidal behaviours in depressive patients receiving pharmacotherapy", Psychol Med (2022)[DOI]
- Hyun-Ju Yang, "The Moderating Effects of Accurate Expectations of Lethality in the Relationships between Suicide Intent and Medical Lethality on Suicide Attempts", Clinical Psychopharmacology and Neuroscience, 20(1), pp.180~184 (2022), 대한정신약물학회[DOI]
